Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Johnson and Johnson
Boehringer Ingelheim
UBS
Queensland Health
Cipla
Cerilliant
Healthtrust
Mallinckrodt
Novartis

Generated: October 17, 2017

DrugPatentWatch Database Preview

PIPERAZINE CITRATE Drug Profile

« Back to Dashboard

What is the patent landscape for Piperazine Citrate, and when can generic versions of Piperazine Citrate launch?

Piperazine Citrate is a drug marketed by Lannett, Luitpold, Alpharma Us Pharms, and Impax Labs. and is included in four NDAs.

The generic ingredient in PIPERAZINE CITRATE is piperazine citrate. There are eighteen drug master file entries for this compound. Additional details are available on the piperazine citrate profile page.

Summary for Tradename: PIPERAZINE CITRATE

US Patents:0
Applicants:4
NDAs:4
Bulk Api Vendors: see list36
Clinical Trials: see list528
Patent Applications: see list79
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PIPERAZINE CITRATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett
PIPERAZINE CITRATE
piperazine citrate
SYRUP;ORAL080963-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Impax Labs
PIPERAZINE CITRATE
piperazine citrate
TABLET;ORAL080874-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Luitpold
PIPERAZINE CITRATE
piperazine citrate
SYRUP;ORAL080671-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Alpharma Us Pharms
PIPERAZINE CITRATE
piperazine citrate
SYRUP;ORAL080774-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Cerilliant
Merck
Boehringer Ingelheim
Fish and Richardson
Mallinckrodt
UBS
Express Scripts
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot